Spirometric criteria for airway obstruction: Use percentage of FEV 1/FVC ratio below the fifth percentile, not < 70%

Chest

Volumn 131, Issue 2, 2007, Pages 349-355

  Hansen, James E ^a   Sun, Xing Guo ^a   Wasserman, Karlman ^a  

^a HARBOR UCLA MEDICAL CENTER   (United States)

Author keywords

Airway obstruction; Percentage of predicted FEV1 FVC; Reference values; Spirometry

Indexed keywords

ADULT; AIRWAY OBSTRUCTION; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; CLINICAL PRACTICE; DISEASE SEVERITY; ETHNIC GROUP; FEMALE; FORCED EXPIRATORY VOLUME; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; REFERENCE VALUE; SPIROMETRY;

EID: 33847096020     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.06-1349     Document Type: Article

References (30)

1. Sobol BJ, Weinheimer B. Assessment of ventilatory abnormality in the asymptomatic subject: an exercise in futility. Thorax 1966; 21:445-449
2. Miller MR, Pincock AC. Predicted values: how should we use them? Thorax 1988; 43:265-267
3. Pelligrino R, Viegi G, Brusasco V, et al. ATS/ERS task force: standardization of lung function testing: interpretative strategies for lung function tests. Eur Respir J 2005; 26:948-968
4. Pauwels RA, Buist AS, Calverley PM, et al. Global strategies for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 2001; 163:1256-1276
5. Guidelines: workshop report; Global strategy for diagnosis, management, and prevention of COPD. Available at: www. goldcopd.com/Guidelineitem.asp?1= 2&12=1&intID=989. Accessed January 2, 2007
6. Celli BR, MacNee W. Standards for diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004; 23:932-946
7. Celli BR, Halpert RJ, Isonaka S, et al. Population impact of different definition of airway obstruction. Eur Respir J 2003; 22:268-273
8. Lundback B, Lindberg A, Lindstrom M, et al. Not 15 but 50% of smokers develop COPD! Report from the Obstructive Lung Disease in Northern Sweden Studies. Respir Med 2003; 97:115-122
9. Fukuchi Y, Nishimura M, Ichinose M, et al. COPD in Japan: the Nippon COPD Epidemiology study. Respirology 2004; 9:458-465
10. Murtaugh E, Heaney L, Gingles J, et al. Prevalence of obstructive lung disease in a general population sample: the NICECOPD study. Eur J Epidemiol 2005; 20:443-453
11. Behrendt CE. Mild and moderate-to-severe COPD in non-smokers: distinct demographic profiles. Chest 2005; 128:1239-1244
12. Kim DS, Kim YS, Jung K-S, et al. Prevalence of chronic obstructive pulmonary disease in Korea. Am J Respir Crit Care Med 2005; 172:843-877
13. Celli BR, Halpert RJ, Nordyke RJ, et al. Airway obstruction in never smokers: results from the Third National Health and Nutrition Examination Survey. Am J Med 2005; 118:1364-1372
14. Brusasco V, Pelligrino R, Rodarte JR. Vital capacities in acute and chronic airway obstruction: dependence on flow and volume histories. Eur Respir J 1997; 10:1316-1320
15. American Thoracic Society. Standardization of spirometry, 1994 update. Am J Respir Crit Care Med 1995; 152:1107-1136
16. US Department of Health and Human Services (DHHS) NCHS. Third National Health and Nutrition Examination Survey, 1988-1994. NHANES III raw spirometry data file. Hyattsville, MD: Centers for Disease Control and Prevention, 2001
17. Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general US population. Am Rev Respir Crit Care Med 1999; 159:179-187
18. Dixon WJ, Massey FJ Jr. Introduction to statistical analysis, third ed, New York, NY: McGraw-Hill, 1969; 461-463
19. Crapo RO, Morris AH, Gardner RM. Reference Spirometric values using techniques and equipment that meet ATS recommendations. Am Rev Respir Dis 1981; 123:659-664
20. Knudson RJ, Lebowitz MD, Holberg CJ, et al. Changes in the normal maximal expiratory flow-volume curve with growth and aging. Am Rev Respir Dis 1983; 127:725-734
21. Roca J, Burgos F, Sunyer J, et al. Reference values for forced spirometry. Eur Respir J 1998; 11:1354-1362
22. Hansen JE, Sun X-G, Wasserman K. Discriminating measures and normal values for expiratory obstruction. Chest 2006; 129:369-377
23. Wilson D, Adams R, Appleton S, et al. Difficulties identifying and targeting COPD and population-attributable risk of smoking for COPD. Chest 2005; 128:2035-2042
24. Miller MR, Grove DM, Pincock AC. Time domain spirogram indices: their variability and reference values in nonsmokers. Am Rev Respir Dis 1985; 132:1041-1048
25. American Thoracic Society. Lung function testing: selection of reference values and interpretative strategies. Am Rev Respir Dis 1991; 144:1201-1218
26. Ferguson GT, Enright PL, Buist AS, et al. Office spirometry for lung health assessment in adults: a consensus statement from the National Lung Health Education Program. Chest 2000; 117:1146-1161
27. 6 is an acceptable surrogate for FVC in the spirometric diagnosis of airway obstruction and restriction. Am J Respir Crit Care Med 2000; 162:917-919
28. 6 predicts lung function decline in adult smokers. Respir Med 2000; 96:444-449
29. 1/FVC and FVC in the spirometric detection of airway obstruction and restriction. Chest 2005; 127:1560-1564
30. Hansen JE, Sun XG, Wasserman K. Should forced expiratory volume in six seconds replace forced vital capacity to detect airway obstruction? Eur Respir J 2006; 27:1244-1250